Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis – pilot phase
2010-024541-67Phase 2Completed
- Sponsor
- NHS Greater Glasgow and Clyde Research & Development
- Start
- Sep 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial in brain infarction and ischemic stroke comparing Tenecteplase arm with Alteplase arm (2 arms). Primary endpoint: Percent penumbral salvage at 24-48 hours. Started Sep 2011; status: completed.
02
Drugs
tenecteplasetissue-plasminogen activator
03
Conditions
brain infarctionischemic stroke
Beyond the preview
Go deeper on 2010-024541-67.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024541-67.